ARTICLE | Clinical News
DaunoXome daunorubicin regulatory update
October 20, 2008 7:00 AM UTC
EMEA's Committee for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation for Diatos' liposomal daunorubicin to treat acute myeloid leukemia (AML). The company, ...